SCHEMBL6007931

SCHEMBL6007931

CC(C)(C)OC(=O)NCC(=O)OC1CCC(O)CC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.45
ALDH1A1 P00352 2/20 0.45
MEN1 O00255 2/20 0.45
TSHR P16473 1/20 0.45
EPHX1 P07099 2/20 0.41
CA12 O43570 1/20 0.39
CA2 P00918 1/20 0.39
CA14 Q9ULX7 1/20 0.39
TDP1 Q9NUW8 1/20 0.38
MAOA P21397 1/20 0.37
MAOB P27338 1/20 0.37
CACNA1B Q00975 4/20 0.37
HCRTR2 O43614 1/20 0.36
GAA P10253 1/20 0.36
EPHX2 P34913 1/20 0.36
GFER P55789 1/20 0.35
APOBEC3A P31941 1/20 0.35
APOBEC3G Q9HC16 1/20 0.35
CTSS P25774 1/20 0.35
CTSK P43235 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2159267 0.94 KMT2A (0.49) KMT2AALDH1A1MEN1TSHREPHX1
SCHEMBL12335551 0.87 EPHX1 (0.50) KMT2AALDH1A1MEN1TSHREPHX1
SCHEMBL5283279 0.86 EPHX1 (0.52) KMT2AALDH1A1MEN1TSHREPHX1
SCHEMBL21614552 0.79 GAA (0.41) ALDH1A1TSHRCACNA1BGAAEPHX2
SCHEMBL27890002 0.78 EPHX1 (0.43) KMT2AALDH1A1MEN1TSHREPHX1
SCHEMBL2177401 0.76 KMT2A (0.51) KMT2AEPHX1CTSSCTSK
SCHEMBL1204998 0.76 KMT2A (0.51) KMT2AEPHX1CTSSCTSK
SCHEMBL1204996 0.76 KMT2A (0.51) KMT2AEPHX1CTSSCTSK
SCHEMBL27999169 0.75 TET2 (0.33) EPHX1GAAEPHX2APOBEC3AAPOBEC3G
SCHEMBL5246848 0.75 NAMPT (0.47) CACNA1BEPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1638950-A2 CYCLOHEXYLGLYCINE DERIVATIVES AS DIPEPTIDYL PEPTIDASE INHIBITORS FOR THE TREATMENT OR PREVENTION OF DIABETES Merck & Co., Inc. (US) 2006-03-29 EP disclosed
WO-2004112701-A2 CYCLOHEXYLGLYCINE DERIVATIVES AS DIPEPTIDYL PEPTIDASE INHIBITORS FOR THE TREATMENT OR PREVENTION OF DIABETES MERCK & CO., INC. (US) 2004-12-29 WO disclosed